Our study is the first to embrace the ITGB2 SNP rs2070946 as a novel genetic biomarker of RA and OA and to report a marked correlation between the C allele and the risk of both diseases that could potentially impact the ITGB2 gene expression. This evidence concerns the gene ITGB2 and rheumatoid arthritis.